Status | Study |
Completed |
Study Name: Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease Condition: Crohn Disease Date: 2010-11-02 Interventions: Drug: Tacrolimus Once daily application for 12 weeks followed by 4 weeks observation. Optional 36 week o |
Completed |
Study Name: Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory Condition: Scabies Impetigo Pyoderma Date: 2009-04-20 |
Completed |
Study Name: Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease Condition: Pyoderma Gangrenosum Crohn's Disease Date: 2008-11-13 Interventions: Drug: Infliximab IV drug given at weeks 1,2,14,22 Ot |
Withdrawn |
Study Name: Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum Condition: Pyoderma Gangrenosum Date: 2008-08-04 Interventions: Drug: Humira Will receive 80 m |
Withdrawn |
Study Name: Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum Condition: Pyoderma Gangrenosum Date: 2008-06-02 Interventions: Drug: adalimumab 40 mg weekly adalimumab injection. |
Completed |
Study Name: Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in Fiji Condition: Streptococcus Group A Date: 2007-02-16 |
Completed |
Study Name: Prevalence of RHD, Pyoderma and Scabies in Children in Fiji Condition: Streptococcus Group A Date: 2006-01-30 |
Completed |
Study Name: Incidence of Group A Strep Pharyngitis in School Children in Fiji Condition: Streptococcus Group A Date: 2006-01-30 |
Withdrawn |
Study Name: Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460) Condition: Pyoderma Date: 2005-09-16 Interventions: Drug: sisomicin |